BioScience Health Innovations (BHIC) Receivables (2023 - 2025)
Historic Receivables for BioScience Health Innovations (BHIC) over the last 3 years, with Q3 2025 value amounting to $63212.0.
- BioScience Health Innovations' Receivables rose 9807.6% to $63212.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $63212.0, marking a year-over-year increase of 9807.6%. This contributed to the annual value of $122083.0 for FY2024, which is 23495.12% up from last year.
- Per BioScience Health Innovations' latest filing, its Receivables stood at $63212.0 for Q3 2025, which was up 9807.6% from $390013.0 recorded in Q2 2025.
- In the past 5 years, BioScience Health Innovations' Receivables ranged from a high of $390013.0 in Q2 2025 and a low of $3849.0 during Q1 2023
- Moreover, its 3-year median value for Receivables was $31913.0 (2024), whereas its average is $74960.5.
- Per our database at Business Quant, BioScience Health Innovations' Receivables surged by 7051.19% in 2024 and then soared by 131155.63% in 2025.
- Over the past 3 years, BioScience Health Innovations' Receivables (Quarter) stood at $36448.0 in 2023, then surged by 234.95% to $122083.0 in 2024, then plummeted by 48.22% to $63212.0 in 2025.
- Its Receivables was $63212.0 in Q3 2025, compared to $390013.0 in Q2 2025 and $93449.0 in Q1 2025.